Clinical trials
Active, not recruiting Pancreatic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amplia Therapeutics Limited | 2 |
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| Monopar Therapeutics | 2 |
| Amgen | 1 |
| Arcus Biosciences, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| Bristol-Myers Squibb | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Colorectal Neoplasms | 9 |
| Ovarian Neoplasms | 9 |
| Stomach Neoplasms | 6 |
| Melanoma | 4 |
| Urinary Bladder Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Transitional Cell | 3 |
| Endometrial Neoplasms | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.